Diagnose HDV infection in patient with documented acute or chronic HBV and at risk for HDV infection. Consider ordering HBV IgM core antibody testing to determine whether HDV infection is a coinfection or a superinfection with HBV.
Qualitative Enzyme Immunoassay
Mon, Wed, Fri
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Also acceptable: Citrate, EDTA, or heparin plasma.
Room temperature specimens. Specimens containing particulate material or obvious microbial contamination. Hemolyzed or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 5 days; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Order this assay only when patient has an acute or chronic hepatitis B infection. This test detects total antibodies (IgG and IgM) to the hepatitis Delta agent.
|Component Test Code*||Component Chart Name||LOINC|
|0020799||Hepatitis Delta Antibody||40727-0|
- HDV Ab